ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma - Prospective Study (ISG/OS-2).
Phase of Trial: Phase II/III
Latest Information Update: 20 Nov 2017
At a glance
- Drugs Cisplatin (Primary) ; Doxorubicin (Primary) ; Ifosfamide (Primary) ; Methotrexate (Primary) ; Mifamurtide (Primary)
- Indications Osteosarcoma
- Focus Therapeutic Use
- 15 Oct 2013 Planned end date changed from 1 Jul 2019 to 1 Feb 2020 as reported by ClinicalTrials.gov.
- 05 Jan 2012 New source identified from European Clinical Trials Database.
- 27 Oct 2011 New trial record